In addition, although it did not reach statistical significance, we observed a trend toward increased mortality at 30 and 90 days among those who discontinued compared with those not started on ACEi/ARB (Table S5 ).
← all excerpts
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
1
—
—